Therapy Areas
17 November 2026 - Norwegian biotech company Oncoinvent ASA (OSE:ONCIN) on Tuesday reported favourable safety and tolerability results from the first interim safety analysis of its randomised phase 2 trial evaluating Radspherin in patients with advan...
17 November 2026 - Canadian pharmaceutical company Apotex Health Corp (TSX:APTX) announced on Monday the US launch of Axitinib Tablets, 1 mg and 5 mg, the first generic version of Pfizer's INLYTA, a kinase inhibitor indicated for the treatment o...
17 November 2026 - Biotechnology company Rakuten Medical Inc announced on Monday that it has initiated a Phase 1 clinical trial of RM-0256 photoimmunotherapy in Japan.RM-0256, an anti-PD-L1 antibody-light-activatable dye conjugate, is the third drug ...
17 November 2026 - Chinese pharmaceutical company Akeso Inc (HKEX:9926) announced on Monday that China's National Medical Products Administration (NMPA) has accepted its supplemental New Drug Application (sNDA) for ivonescimab in combination wit...
16 November 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that it has received US Food and Drug Administration (FDA) approval for Gazyva (obinutuzumab) to treat adults with prim...
16 November 2026 - Specialist HIV company ViiV Healthcare, majority owned by GSK (LON:GSK), with Shionogi as a shareholder, said on Monday that it has received a positive recommendation from the European Medicines Agency's Committee for Medicina...
16 November 2026 - UK biotechnology company TRIMTECH Therapeutics announced on Monday that it has entered into a strategic research collaboration, option and licence agreement with Biogen International GmbH, part of US biotechnology company Biogen In...